More from the company: WntResearch på Sedermeradagen

More from the company: WntResearch på Sedermeradagen

More from the company: WntResearch på Sedermeradagen

Press release from Companies: WntResearch focus the enrollment of patients in Phase 1 with Foxy-5

Press release from Companies: WntResearch focus the enrollment of patients in Phase 1 with Foxy-5

Press release from Companies: WntResearch fokuserar rekryteringen av patienter i företagets fas 1 studie med Foxy-5

Press release from Companies: WntResearch fokuserar rekryteringen av patienter i företagets fas 1 studie med Foxy-5

Press release from Companies: WntResearch fokuserar rekryteringen av patienter i företagets fas 1 studie med Foxy-5

Press release from Companies: WntR updates information from the European Patent Office, which has granted patent on peptides related to Foxy-5 - Corrected version

Press release from Companies: WntR updates information from the European Patent Office, which has granted patent on peptides related to Foxy-5 - Corrected version

Press release from Companies: WntR updates information from the European Patent Office, which has granted patent on peptides related to Foxy-5 - Corrected version

Press release from Companies: WntR updates information from the European Patent Office, which has granted patent on peptides related to Foxy-5 - Corrected version